** Shares of Advance ZincTek ANO.AX rise as much as 3.5%
to A$3.300, posting their biggest intraday pct gain since Nov.
16
** Sunscreen ingredients maker says https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02467725-2A1346518?access_token=83ff96335c2d45a094df02a206a39ff4
indicated sales forecast for H2 FY22 better than FY21 total
sales of A$6.5 mln ($4.65 mln)
** Says improvements in co's website and information
released by the U.S. Food and Drug Administration have led to
increased inquiries about samples or materials of ANO's
zinc-based products
** However, co cuts H1 FY22 estimated sales to about A$5.5
mln from A$7.1 mln
** Says ANO continues to experience delays in billable sales
as the Delta and Omicron variants of coronavirus adversely
affect the industry
** Stock hits its highest level since Dec. 9
** As of last close, stock down ~27.2% YTD
($1 = 1.3972 Australian dollars)
(Reporting by Upasana Singh in Bengaluru)
((Upasana.Singh@thomsonreuters.com))